Drug Research

It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with MDD diagnoses and the unmet demand. In light of this, the time is right for the...

Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US. Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was authorised by the FDA on August 17, two days before the FDA's scheduled approval action...

As it works to expand its antibody-drug conjugate (ADC) capabilities, Merck has strengthened its links to Starpharma by signing a second partnership that will allow it to assess potential candidates using a dendrimer drug delivery technology. Merck and Starpharma agreed...

While a large portion of the biopharma industry prepares for a battle over medication prices, Bayer is getting ready for a different lobbying push of its own. A disclosure form reveals that Bayer has hired a team of lobbyists to...

Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise in halting tumour development in HR-positive HER2-negative breast cancer. Now that the drugmaker has unexpectedly returned with that victory, industry observers are still unconvinced. According...

A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, sought to build on earlier findings from his lab that showed ALT tumours...

A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through the mucosal tissues in the nose, which could result in improved defence against pathogens like...